4.8 Article

Microfluidic organs-on-chips

Journal

NATURE BIOTECHNOLOGY
Volume 32, Issue 8, Pages 760-772

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.2989

Keywords

-

Funding

  1. Defense Advanced Research Projects Agency (DARPA) [W911NF-12-2-0036]
  2. FDA [HHSF223201310079C]
  3. US National Institutes of Health [UH3 EB017103, R01 DK85713, R01 EB008396]
  4. Bill and Melinda Gates Foundation [OPP1023607, OPP1086223]
  5. Wyss Institute for Biologically Inspired Engineering at Harvard University
  6. US Department of Defense (DoD) Breast Cancer Innovator Award [BC074986]
  7. Bill and Melinda Gates Foundation [OPP1086223, OPP1023607] Funding Source: Bill and Melinda Gates Foundation

Ask authors/readers for more resources

An organ-on-a-chip is a microfluidic cell culture device created with microchip manufacturing methods that contains continuously perfused chambers inhabited by living cells arranged to simulate tissue-and organ-level physiology. By recapitulating the multicellular architectures, tissue-tissue interfaces, physicochemical microenvironments and vascular perfusion of the body, these devices produce levels of tissue and organ functionality not possible with conventional 2D or 3D culture systems. They also enable high-resolution, real-time imaging and in vitro analysis of biochemical, genetic and metabolic activities of living cells in a functional tissue and organ context. This technology has great potential to advance the study of tissue development, organ physiology and disease etiology. In the context of drug discovery and development, it should be especially valuable for the study of molecular mechanisms of action, prioritization of lead candidates, toxicity testing and biomarker identification.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available